Table 1. NK cell and T cell cytotoxicity toward the K562 erythroleukemia target cell line in 2 patients with XLPDR and patient P6 with the POLA1 c.328G>A mutation.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.